Consultant Oncologist, KPJ Sabah Specialist Hospital (BMed Sci, BMBS Nottingham University, UK , MRCP (UK), FRCR (UK), CCST (UK))
BIOGRAPHY
Speaker
Abstract
In this presentation, we will discuss:
- Prevalence & prognosis of PIK3ca mutation in HR+/HER2- BC
- Current SOC for MBC
- Summary of SOLAR-1 study (clinical evidence of pi3k-i targeting this specific mutation)
- When to perform testing & clinical consideration